| Literature DB >> 35058965 |
Kan Li1,2, Weichen Huang1,2, Zhijun Wang1,2, Yangfeng Chen1,2, Danfeng Cai1,2, Qinghua Nie1,2.
Abstract
Recent studies have shown that circular RNAs (circRNAs) play important roles in skeletal muscle development. CircRNA biogenesis is dependent on the genetic context. Single-nucleotide polymorphisms in the introns flanking circRNAs may be intermediate-inducible factors between circRNA expression and phenotypic traits. Our previous study showed that circTAF8 is an abundantly and differentially expressed circRNA in leg muscle during chicken embryonic development. Here, we aimed to investigate circTAF8 function in muscle development and the association of the SNPs in the circTAF8 flanking introns with carcass traits. In this study, we observed that overexpression of circTAF8 could promote the proliferation of chicken primary myoblasts and inhibit their differentiation. In addition, the SNPs in the introns flanking the circTAF8 locus and those associated with chicken carcass traits were analyzed in 335 partridge chickens. A total of eight SNPs were found associated with carcass traits such as leg muscle weight, live weight, and half and full-bore weight. The association analysis results of haplotype combinations were consistent with the association analysis of a single SNP. These results suggest that circTAF8 plays a regulatory role in muscle development. These identified SNPs were found correlated with traits to muscle development and carcass muscle weight in chickens.Entities:
Keywords: carcass traits; chicken; circTAF8; flanking introns; muscle development; non-coding RNA; snps
Year: 2022 PMID: 35058965 PMCID: PMC8764441 DOI: 10.3389/fgene.2021.743757
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
FIGURE 1Identification of circTAF8 in chicken. (A) Genomic location and looping model of circTAF8 and Sanger sequencing results. (B) Electrophoresis results of circTAF8 amplified from cDNA and gDNA with divergent and convergent primers, respectively. (C) Reverse transcription-polymerase chain reaction (RT-PCR) assays to detect β-actin, TAF8, circTAF8, and circHIPK3 RNA expression levels with and without RNase R treatment. (D) RT-PCR to detect circTAF8 and TAF8 RNA expression levels with and without actinomycin D treatment. (E) RT-PCR results showing the circTAF8 subcellular localization. (F) RT-PCR results showing the circTAF8 expression level in XH and WRR groups. (G) Relative RNA expression level of circTAF8 in diverse tissues. (H) Relative TAF8 RNA levels in diverse tissues. (I) The relative levels of TAF8 RNA and circTAF8 in each tissue. The results of are shown as mean ± S.E.M from at least three biological replicates. The statistical significance of the differences was assessed using the unpaired Student’s t-test or one-way analysis of variance (ANOVA) (* p < 0.05; **p < 0.01; ***p < 0.001; **** p < 0.0001).
FIGURE 2CircTAF8 promote the proliferation of myoblasts. (A) The relative expression level of circTAF8 after transfecting chicken primary myoblast (CPMs) with pCD25-ciR-circTAF8 or pCD25-ciR. (B) Cell-cycle analysis of CPMs transfected with pCD25-ciR-circTAF8 and pCD25-ciR for 36 h. ( C) CCK8 analysis of CPMs transferred with pCD25-ciR-circTAF8 and pCD25-ciR. (D) 5-Ethynyl-2′-deoxyuridine (EdU) staining assays for CPMs transferred with pCD25-ciR-circTAF8 and pCD25-ciR for 48 h. (E) Fold change in proliferation rates of CPMs upon transfection with pCD25-ciR-circTAF8 or pCD25-ciR for 48 h. (F) Relative mRNA levels of proliferation-related genes after transfection of CPM pCD25-ciR-circTAF8 or pCD25-ciR. The data are shown as the mean ±(S.E.M) from at least three biological replicates. The statistical significance of the differences was assessed using the unpaired Student’s t-test (* p < 0.05; **p < 0.01; ***p < 0.001; **** p < 0.0001).
FIGURE 3CircTAF8 inhibits myoblast differentiation. (A) Reverse transcription–polymerase chain reaction results showing the mRNA level of the cell differentiation-related genes in CPMs upon transfection with pCD25-ciR-circTAF8 or pCD25-ciR. (B) Western blot results showing the MYOD and MYOG protein levels in CPMs upon transfection with pCD25-ciR-circTAF8 or pCD25-ciR. (C) MyHC Immunofluorescence analysis of the myotubes transfected with pCD25-ciR-circTAF8 or pCD25-ciR. (D) Relative circTAF8 RNA level at various timepoints during myoblast differentiation. (E) Relative TAF8 RNA levels at various timepoints during myoblast differentiation. The results are shown as mean ± S.E.M from at least three biological replicates. The statistical significance of the differences was assessed using the unpaired Student’s t-test or one-way analysis of variance (ANOVA) (* p < 0.05; **p < 0.01).
Association of eight SNPs in introns flanking circTAF8 with carcass traits.
| SNP | Trait |
| Least square mean ± standard error | ||
|---|---|---|---|---|---|
| g.-1771 G > C | GG (n = 6) | GC (n = 103) | CC (n = 214) | ||
| FBW(g) | 0.037 | 1,128.33 ± 22.70a | 1,078.48 ± 6.30 | 1,071.99 ± 4.93a | |
| SL (mm) | 0.004 | 71.88 ± 1.58A | 66.44 ± 0.44B | 66.82 ± 0.35AB | |
| AFW(g) | 0.044 | 35.57 ± 4.32 | 26.52 ± 1.20 | 25.24 ± 0.95 | |
| g.-1576A > G | AA (n = 253) | AG (n = 63) | GG (n = 7) | ||
| HBW(g) | 0.030 | 1,290.27 ± 8.53a | 1,252.62 ± 15.22a | 1,333.36 ± 42.56 | |
| g.-1554 T > C | TT (n = 21) | TC (n = 105) | CC(n = 197) | ||
| LMW(g) | 0.001 | 253.78 ± 15.71AB | 192.21 ± 7.55A | 196.10 ± 5.75B | |
| g.-1480A > C | AA (n = 21) | AC (n = 107) | CC(n = 195) | ||
| LMW(g) | 0.001 | 254.39 ± 15.71AB | 192.36 ± 7.43A | 196.01 ± 5.87B | |
| g.-289 C > T | CC(n = 88) | CT (n = 143) | TT (n = 83) | ||
| LWBS(g) | 0.022 | 1,608.47 ± 9.92a | 1,599.25 ± 7.89 | 1,629.83 ± 9.97a | |
| HBW(g) | 0.045 | 1,278.47 ± 13.18 | 1,275.18 ± 10.16 | 1,312.68 ± 13.26 | |
| FBW(g) | 0.012 | 1,072.26 ± 6.63 | 1,068.22 ± 5.20a | 1,090.64 ± 6.66a | |
| g.-288A > G | AA (n = 72) | AG (n = 157) | GG (n = 85) | ||
| LWBS(g) | 0.012 | 1,615.45 ± 10.66 | 1,597.32 ± 7.77a | 1,628.30 ± 9.84a | |
| HBW(g) | 0.046 | 1,280.74 ± 14.32 | 1,274.13 ± 9.92a | 1,311.62 ± 13.06a | |
| FBW(g) | 0.007 | 1,076.01 ± 7.14 | 1,066.81 ± 5.09A | 1,090.05 ± 6.55A | |
| WW(g) | 0.034 | 64.23 ± 0.55 | 64.18 ± 0.41a | 65.55 ± 0.5a | |
| g.-210 T > C | TT (n = 67) | TC (n = 158) | CC(n = 89) | ||
| LWBS(g) | 0.017 | 1,612.00 ± 11.02 | 1,598.30 ± 7.82a | 1,628.94 ± 9.80a | |
| HBW(g) | 0.036 | 1,292.94 ± 14.88 | 1,270.77 ± 9.91a | 1,308.98 ± 12.91a | |
| FBW(g) | 0.002 | 1,075.76 ± 7.38 | 1,065.75 ± 5.11A | 1,092.10 ± 6.50A | |
| WW(g) | 0.048 | 64.39 ± 0.57 | 64.14 ± 0.41a | 65.48 ± 0.51a | |
| g.-173A > G | AA (n = 66) | AG (n = 160) | GG (n = 88) | ||
| FBW(g) | 0.004 | 1,075.28 ± 7.32 | 1,066.41 ± 5.09A | 1,090.77 ± 6.42A | |
| WW(g) | 0.047 | 64.53 ± 0.56 | 64.10 ± 0.41a | 65.43 ± 0.50a | |
The above values are “average values ± standard errors”; in each group of SNPs, unmarked letters in the same line indicate that the difference is not significant (p > 0.05). When the letters are the same, lowercase letters indicate significant differences (p < 0.05), and uppercase letters indicate significant differences (p < 0.01).
FIGURE 4LinKage disequilibrium analysis among 8 SNPs in the introns flanking of circTAF8. The linkage among SNPs was evaluated based on Dʹ and r . (A) Dʹ on the left. Dʹ = 1 indicates full linkage, Dʹ = 0 indicates no linkage or linkage equilibrium. (B) r on the right. r = 1 indicates full linkage, r > 0.33 indicates strong linkage, r = 0 indicates no linkage or linkage equilibrium.
Association of the combinations of TAF8 haplotypes with carcass traits.
| Group | Traits | Least square mean ± standard error | |||||
|---|---|---|---|---|---|---|---|
| 1 | CCAC | CCCC | TCAC | TTAA |
| ||
| LMW | 196.77 ± 29.13 | 195.92 ± 5.93A | 193.02 ± 7.72B | 257.328 ± 16.15AB | 0.024 | ||
| 2 | CCAATCAA | CCAATTAA | CCAGTCAG | CTAGTCAG | TTGGCCGG |
| |
| LWBS | 1,648.41 ± 32.97 | 1,612.11 ± 11.12 | 1,582.80 ± 20.66 | 1,598.61 ± 8.06 | 1,631.47 ± 10.08 | 0.02 | |
| HBW | 1,152.30 ± 46.55aB | 1,292.32 ± 15.19 | 1,271.24 ± 29.05 | 1,276.11 ± 10.61 | 1,314.13 ± 13.55B | 0.007 | |
| FBW | 1,073.51 ± 22.19 | 1,075.37 ± 7.48 | 1,057.68 ± 13.90 | 1,066.23 ± 5.43A | 1,092.37 ± 6.78A | 0.011 | |
| LMW | 198.65 ± 29.93 | 196.23 ± 9.68A | 271.25 ± 18.67ABC | 194.16 ± 6.68B | 199.32 ± 8.86C | 0.003 | |
Group 1 indicates haplotype combination of g.-1554 T > C and g.-1480A > C.
Group 2 indicates haplotype combination of g.-289 C > T, g.-288A > G, g.-210 T > C, and g.-173A > G.
The above values are “mean values ± standard errors”; in each group of SNPs, unmarked letters in the same line indicate that the difference is not significant (p > 0.05). When the letters are same, lowercase letters indicate significant differences (p < 0.05), and uppercase letters indicate significant differences (p < 0.01).
FIGURE 5Sequence alignment information. (A) The global alignment of introns flanking circTAF8. (B) The short reverse complementary sequences of SNPs in flanking introns of circTAF8.